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erate, for a less exact diagnosis than with
smeared cells. The run-across method,
which is smeared cell cytologic examina-
tion—the glass slide is run across the
whole of the surgical margin4,5—is so sim-
ple and little contaminated that the malig-
nant positive rate on the surgical margin of
excised resected non–small cell lung can-
cer has been higher than with Higashiyama
and colleagues’ technique.1 Whether the
run-across method is more sensitive or Hi-
gashiyama and colleagues’ technique is
less accurate has been unclear, because
both studies1,2 have small numbers of pa-
tients with malignant positive margins.
Further study is needed to find the signifi-
cance of malignant status on the surgical
margin of limited-resected resected non–
small cell lung cancer.
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Reply to the Editor:
We appreciate the questions raised by
Sawabata in his letter about our article. In
this article,1 as well as the preliminary re-
port,2 we emphasized that this novel intra-
operative lavage cytologic technique in
limited surgery for lung cancer is clinically
useful in checking for complete resection
of the primary lesion. This technique is
also widely applied in metastasectomy for
metastatic pulmonary tumors.3
One of Sawabata’s questions is a prob-
lem of tumor cell contamination from the
pleural surface when surgical margins of
the resected specimens are washed. As de-
scribed in our article,1,2 when limited sur-
gery is performed with a stapler alone, only
all fired cartridges are washed, and there-
fore it is out of problem. When limited
surgery is performed with the electric scis-
sors or Nd:YAG laser, the specimen should
be carefully washed without flooding of
pleural surface. However, it is sometimes
difficult to avoid flooding the pleura. When
the pleural surface is carelessly washed, the
result of intrathoracic pleural lavage cyto-
logic examination immediately after thora-
cotomy should be taken into consider-
ation4: Even if the surgical margin is
cytologically positive, limited surgery is
usually finished when pleural lavage cyto-
logic examination is positive; when it is
negative, the surgical mode should be care-
fully converted, considering together mac-
roscopic and microscopic findings of sur-
gical margin, especially in intentional
cases.
Another question is a problem of the
rate of positive cytologic results in the sur-
gical margin after limited surgery for lung
cancer. By Sawabata and colleagues’ “run-
across” method5, the positive cytologic rate
in the surgical margin was surprisingly
high (47%), whereas it was lower (10%) by
our method. We speculate that this result
may be due to the difference of the clini-
copathologic backgrounds of the tested pa-
tients. The data from Sawabata and col-
leagues’ method were obtained in only 15
compromised limited cases,5 whereas those
from ours1 were in not only 55 compro-
mised but also 57 intentional limited cases.
The number of Sawabata and colleagues’
tested patients was too small.5 Moreover, it
may be reasonable that the rate in compro-
mised cases was higher than that in inten-
tional cases. In fact, the rate of positive
cytologic results in compromised cases in
our series was 18%.1 Thus in compromised
limited surgery the positive cytologic rate
in the surgical margins may be strongly
dependent on tumor size, tumor location,
and, importantly, surgical cutting technique
and indication for limited surgery. There-
fore, because the positive cytologic rate in
intentional limited surgery is rather more
important, such data obtained by Sawabata
and colleagues’ method5 should be shown.
We think that the cause of the rate in our
article1 was not that the sensitivity of our
cytologic technique was low. Comparative
analysis is also needed between the “run-
across” technique and our novel technique
in checking accurately the surgical margins
status of limited surgery for lung cancer.
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